DNASE1 | Deoxyribonuclease I | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DNPEP | Aspartyl aminopeptidase | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DSC3 | Desmocollin 3 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
DSG2 | Desmoglein 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
DYSF | Dysferlin | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
ECI2 | Enoyl-CoA delta isomerase 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
EEF1E1 | Eukaryotic translation elongation factor 1 epsilon 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EIF2S3 | Eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
EIF4G1 | Eukaryotic translation initiation factor 4 gamma, 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ELOVL1 | ELOVL fatty acid elongase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ELP4 | Elongator acetyltransferase complex subunit 4 | Predicted intracellular proteins
| | | | | Expressed in all |
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
EMC3 | ER membrane protein complex subunit 3 | Predicted membrane proteins
| | | | | Expressed in all |
EMD | Emerin | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
ENDOD1 | Endonuclease domain containing 1 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ENG | Endoglin | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ENTPD4 | Ectonucleoside triphosphate diphosphohydrolase 4 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
EPDR1 | Ependymin related 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
EPHA2 | EPH receptor A2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ERAP2 | Endoplasmic reticulum aminopeptidase 2 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ERCC2 | Excision repair cross-complementation group 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ERLIN1 | ER lipid raft associated 1 | Predicted secreted proteins
| | | | | Expressed in all |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
EVI5L | Ecotropic viral integration site 5-like | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
F11R | F11 receptor | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
FAM162A | Family with sequence similarity 162, member A | Predicted membrane proteins
| | | | | Expressed in all |
FAM213A | Family with sequence similarity 213, member A | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FAM3C | Family with sequence similarity 3, member C | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FANCI | Fanconi anemia, complementation group I | Disease related genes Predicted intracellular proteins
| | | | | Mixed |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
FBLN1 | Fibulin 1 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FDXACB1 | Ferredoxin-fold anticodon binding domain containing 1 | Predicted intracellular proteins
| | | | | Mixed |
FKBP10 | FK506 binding protein 10, 65 kDa | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
FLNA | Filamin A, alpha | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FLNB | Filamin B, beta | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FMNL1 | Formin-like 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FMR1NB | Fragile X mental retardation 1 neighbor | Predicted membrane proteins
| | | | | Tissue enriched |
FRYL | FRY-like | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
FUT8 | Fucosyltransferase 8 (alpha (1,6) fucosyltransferase) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FXYD5 | FXYD domain containing ion transport regulator 5 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
GALK2 | Galactokinase 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
GALNT7 | Polypeptide N-acetylgalactosaminyltransferase 7 | Predicted intracellular proteins
| | | | | Mixed |
GART | Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
GCLC | Glutamate-cysteine ligase, catalytic subunit | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |